EUVIMEDEUVIMED entdecken
Crossref

Suppression of Metastasis and Angiogenesis by Taxifolin Ruthenium- p -cymene Loaded PLGA Nanoparticles in Lung Carcinoma

Abhijit Das, Barshana Bhattacharya, Sakuntala Gayen, Souvik Roy iD

Molecular Pharmaceutics · 04.11.2024 · 21 (11) · 5482-5496

DOI: 10.1021/acs.molpharmaceut.4c00306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 27.09.2024. Verfasst von Abhijit Das und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata 700053, West Bengal, India. Hauptthemen laut MEDLINE: Cymenes, Lung Neoplasms, Nanoparticles, Quercetin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flavonoid-based organometallic complexes were revealed to be novel bioactive compounds. The taxifolin ruthenium-p-cymene nanoparticle (TaxRu-NPs) was produced in this study, and the toxicological assessment was done prior to in vivo chemotherapeutic research. Furthermore, the in vitro chemotherapeutic investigation used the A549 and NCI-H460 lung cancer cell lines. The in vitro study found that TaxRu-NPs induced apoptosis in lung cancer cells and hindered their ability to form colonies and migrate. The in vivo study showed that treatment with TaxRu-NPs restored the histological structure of a normal lung with less hyperplasia and lymphocytic infiltration. Furthermore, the treatment downregulated the angiogenic marker VEGF and the cell survival protein β-catenin and upregulated apoptotic markers like p53 and caspase-3. TaxRu-NPs treatment additionally raised the apoptotic index and decreased cancer cell growth. Finally, TaxRu-NPs effectively alleviate lung cancer by activating p53-mediated apoptosis and preventing angiogenesis and metastasis by decreasing the VEGF/β-catenin pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CymenesLung NeoplasmsNanoparticlesQuercetinApoptosisNeovascularization, PathologicHumansAnimalsCell Line, TumorA549 CellsMicePolylactic Acid-Polyglycolic Acid CopolymerRutheniumVascular Endothelial Growth Factor ACell Proliferationbeta CateninTumor Suppressor Protein p53MonoterpenesAngiogenesis

Stichwörter der Autor:innen

PLGA nanoparticlesangiogenesislung carcinomaruthenium-p-cymenetaxifolin

Substanzen

CymenesQuercetin4-cymenetaxifolinPolylactic Acid-Polyglycolic Acid CopolymerRutheniumVascular Endothelial Growth Factor Abeta CateninTumor Suppressor Protein p53Monoterpenes

Autor:innen und Institutionen

  • Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata 700053, West Bengal, India.

ORCID-Profile: Souvik Roy

Zitieren

APA

Das, A., Bhattacharya, B., Gayen, S., & Roy, S. (2024). Suppression of Metastasis and Angiogenesis by Taxifolin Ruthenium- p -cymene Loaded PLGA Nanoparticles in Lung Carcinoma. Molecular Pharmaceutics, 21(11), 5482-5496. https://doi.org/10.1021/acs.molpharmaceut.4c00306

Vancouver

Das A, Bhattacharya B, Gayen S, Roy S. Suppression of Metastasis and Angiogenesis by Taxifolin Ruthenium- p -cymene Loaded PLGA Nanoparticles in Lung Carcinoma. Molecular Pharmaceutics. 2024;21(11):5482-5496. doi:10.1021/acs.molpharmaceut.4c00306

BibTeX
@article{Das2024,
  author = {Das, Abhijit and Bhattacharya, Barshana and Gayen, Sakuntala and Roy, Souvik},
  title = {Suppression of Metastasis and Angiogenesis by Taxifolin Ruthenium- p -cymene Loaded PLGA Nanoparticles in Lung Carcinoma},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {11},
  pages = {5482--5496},
  doi = {10.1021/acs.molpharmaceut.4c00306}
}
Kostenlos starten →